Journal List > J Menopausal Med > v.22(1) > 1092765

Kim, Kim, and Lee: The Relevance of Women's Diseases, Jun Activation-domain Binding Protein 1 (JAB1) and p27kip1

Abstract

The Jun activation-domain binding protein 1 (Jab1) recognize a potential coactivator of activator protein 1 (AP-1) such as c-fos, c-jun transcription factor and the fifth subunit of the COP9 signalosome complex. Also, Jab1 activate the c-jun gene resulted cell proliferation. Not only a powerful tumor suppressor but also regulator of apoptosis negative cdk inhibitor p27kip1 are involved in the cell cycle. This is Jab1 and p27kip1 interact with each other, Jab1 accelerate p27kip1 from nuclear to cytoplasm through ubiquitin/proteasome pathway. However, information about the relationship between Jab1 and p27kip1 is not known much. Taken together, the results of this study identify function and structure of Jab1 and p27kip1 were described in a recent article on the basis of relevant. Besides Jab1 and p27kip1 will organize the relationship between the disease and women.

Introduction

The Jun activation-domain binding protein 1 (Jab1) is initially identified as a coactivator of activator protein (AP-1) transcription factor and found a component of the COP9 signalosome (CSN) complex, contained modulating signal transduction, gene transcription, and protein stability.12 Jab1 interacted with p27kip1 and translocate it's from nuclear to cytoplasm which resulted in acceleration of p27kip1 degradation through the ubiquitin-dependent/proteasome pathway and promotes cell-cycle progression.3 p27kip1 is an inhibitor of cyclin-dependent kinases (CDKs), performing potential tumor suppressor gene in diversity of human's cancer. CDK is a family of protein kinases, the activity of the serine/threonine kinases known as cdk that are under the strict control of positive and negative regulators. Until now studies have found that p27kip1 promotes apoptosis, growth inhibition and cell cycle arrest.45 Reduction of p27kip1 protein means high resistance and poor prognosis to anticancer drug. Down regulation of p27kip1 protein is often discovered by human cancers including breast and ovarian cancer and is normally correlated with poor clinical outcome. As a result, the concentration of the p27kip1 protein can be expressed as an important marker in the development of human cancer. Accordingly, this study examines a correlation of p27kip1 and Jab1, will reveal the relevant disease in women.

Jab1, p27Kip1 Structure and Function

Jab1 has been involved to the tumorigenic process, therefore, jab1 have the potential to be an effective beneficial target that affect the interaction of many tumor stage. Size of Jab1 is an -40 kDa soluble protein, also Jab1 is located on chromosome 8. Jab1 interacted with p27kip1 and improved its cytoplasmic translocation which resulted in acceleration of p27kip1 degradation through the ubiquitin and proteasome pathway. It is well known that p27kip1 protein levels are mainly regulated through degradation by ubiquitin-dependent proteolysis. Control of p27kip1 and Jab1 is important process in cancer progression, which is controlled by both the positive and negative regulators. p27kip1 is a kind of cdk inhibitors, suppresses the G1-to-S cell cycle progression, functions as a main negative regulator of apoptosis and is, thus, considered a tumor suppressor.6 The main function of this p27kip1 is to inhibit the CDK2-cyclin E complex by controlling at the G1 to S tarnsition in normal cells.

Jab1, p27kip1 and Breast Cancer

Jab1 is an important protein in breast cancer progression comes from the recent study that it is a downstream target for HER2-2/neu.7 Amplification and overexpression of HER-2/neu was established in many cancers and upregulating of this oncogene was associated with increased metastasis and prognosis. Especially, HER-2/neu oncogene (known for erbB2) is a critical biomarker, target of therapy for roughly 30% of breast cancer patients and expression of HER-2/neu is upregulated in the existence of tamoxifen, leading to tamoxifen resistance in breast cancer. The role of Jab1 interacts with c-myc gene in breast cancer cells.8 C-myc is regulator gene, including apoptosis, transformation, metabolism and cell cycle progression. On the other hand, the lower level of p27 in breast tumors was high grade. Estrogen receptor-negative and progesterone receptor-positive p27 showed a positive correlation between low levels in breast cancer.

P27kip1 and Endometriosis

Endometriosis is the endometrial tissue in the uterus that should be present in the abdominal cavity outside the uterus,9 a common disease that occurs in approximately 10 to 15% woman of childbearing age. The cause of endometriosis, though not known as yet, regurgitation of menstrual blood, immunological factors, genetic factors and family history factors have been established occurrence of endometriosis. According to previous research compared to the healthy women were reported for endometriosis and endometriosis in infertile women, following studies have been reported to demonstrate the changes in the endometrium of women with disease.1011 Moreover the before-mentioned transformation demanded the establishment of the endometrium in the peritoneal, recent evidence indicated that uterine mucosal cells of patients with endometriosis do not follow the normal growth pattern and apoptosis.121314 In the midst of CDK inhibitors, we should be focused on p27kip1. The critical function of p27kip1 is to inhibit CDK-cyclin E complex by controlling a checkpoint in the G1 in normal cells. When p27kip1 is not present in the cells, cells are not follow a cell cycle control signal and proliferation.15 Because endometrial cell cycle changes may be involved in cell cycle regulation of endometriosis in women with diseases significance of p27kip1 protein level it can be seen that a change in the lining of a particular cell cycle is important.

Jab1, p27 and Ovarian Cancer

Ovarian cancer is malignant tumor, the most widely occurring between 50 to 70 years old woman.1617 The second most common cause of gynecologic cancer in succession cervical cancer has been identified as a family history, a lot of ovulation number. No proven method for ovarian cancer is often rapidly progressive and fatal disease early symptoms rarely.5 As a negative regulator of the cell cycle, p27kip1 is tumor suppressor,6 which inhibits cyclin-CDK in a dosage dependent manner to control cell cycle progression.78 Recently, decreased expression of p27kip1 has been frequently detected in human cancers,5101112131415 including ovarian carcinoma. Recently, the expression of Jab1 and p27kip1 in a malignant epithelial ovarian cancer, was found to be correlated with the reverse p27kip1 expression levels as a result Jab1 negative regulator.18 That is a negative regulator of p27kip1 Jab1 has been associated with the development of the ovarian tumor, progression and prognosis.

Summary

Jab1 is a protein that enhances the activity of the c-jun gene and induce cell proliferation, p27kip1 is a strong reduction in the tumor suppressor gene p27kip1 has a high resistance and poor prognosis in cancer. Also p27kip1 has an important role cell cycle regulatory factors. Recently, Jab1 and p27kip1 has been reported that many women involved in diseases such as breast cancer, endometriosis and ovarian cancer. As well as Jab1 and p27kip1 started to reveal that the association became known widely in hepatocellular carcinoma, laryngeal carcinoma and nerves. In conclusion, a wide range of research on Jab1 and p27kip1 is expected to play a major role in reproductive system, kidney, blood vessel tissues and nerves system further physiological pathophysiological.

Acknowledgement

This work was supported by the Soonchunhyang University Research Fund.

Notes

Conflict of Interest No potential conflict of interest relevant to this article was reported.

References

1. Chamovitz DA, Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep. 2001; 2:96–101.
2. Schwechheimer C, Deng XW. COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol. 2001; 11:420–426.
3. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature. 1999; 398:160–165.
4. Chen F, Kim E, Wang CC, Harrison LE. Ciglitazone-induced p27 gene transcriptional activity is mediated through Sp1 and is negatively regulated by the MAPK signaling pathway. Cell Signal. 2005; 17:1572–1577.
5. Zhang Q, Tian L, Mansouri A, Korapati AL, Johnson TJ, Claret FX. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells. FEBS Lett. 2005; 579:3932–3940.
6. Bloom J, Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol. 2003; 13:41–47.
7. Hsu MC, Chai CY, Hou MF, Chang HC, Chen WT, Hung WC. Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu. Mod Pathol. 2008; 21:609–616.
8. Adler AS, Lin M, Horlings H, Nuyten DS, van de, Chang HY. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet. 2006; 38:421–430.
9. Kim TH, Lee HH, Chung SH, Park J, Lee A. Expression of p27 and Jun activation domain-binding protein 1 in endometriosis. Arch Gynecol Obstet. 2015; 292:377–381.
10. Fedele L, Marchini M, Bianchi S, Dorta M, Arcaini L, Fontana PE. Structural and ultrastructural defects in preovulatory endometrium of normo-ovulating infertile women with minimal or mild endometriosis. Fertil Steril. 1990; 53:989–993.
11. Giudice LC, Kao LC. Endometriosis. Lancet. 2004; 364:1789–1799.
12. Wingfield M, Macpherson A, Healy DL, Rogers PA. Cell proliferation is increased in the endometrium of women with endometriosis. Fertil Steril. 1995; 64:340–346.
13. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril. 1998; 69:1042–1047.
14. Dmowski WP, Ding J, Shen J, Rana N, Fernandez BB, Braun DP. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod. 2001; 16:1802–1808.
15. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004; 54:8–29.
16. Park JM, Kim MK. Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistry. J Menopausal Med. 2014; 20:14–20.
17. Lee WS, Park ES, Kim DH, Kim TH, Lee HH, Chung SH. Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors. Eur J Gynaecol Oncol. 2012; 33:358–362.
18. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, et al. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res. 2001; 7:4130–4135.
TOOLS
Similar articles